The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.20
Bid: 104.80
Ask: 105.60
Change: 1.40 (1.35%)
Spread: 0.80 (0.763%)
Open: 102.00
High: 106.20
Low: 102.00
Prev. Close: 103.80
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

10 Nov 2011 07:00

RNS Number : 8235R
PZ CUSSONS PLC
10 November 2011
 



 

PZ CUSSONS PLC

 

10 November 2011

Changes to the Board of Directors

Appointment of Non-executive Directors

 

PZ Cussons plc ("PZ Cussons" or the "Company") is pleased to announce the appointment to the Board of two Non-executive Directors.

 

Helen Owers and Ngozi Edozien will each join the Board as Non-executive Directors on 1 January 2012.

 

Helen Owers is Chief Development Officer for Thomson Reuters Professional, with responsibility for the company's expansion in Rapidly Developing Economies. She has previously held a number of operational roles within the Thomson Reuters group and played an important role in the development of the company's digital strategy. Most recently as President of Global Businesses for Thomson Reuters Legal, she built new businesses in a number of emerging markets, balancing local consumer insights and needs with the globalisation of the business and key products. Before joining Thomson Reuters, Helen worked as a consultant with Gemini Consulting, developing and implementing corporate and operational strategies for a number of consumer products clients.  

 

Ngozi Edozien is Chief Executive, West Africa at Actis, a leading private equity investor in emerging markets, where she is responsible for all aspects of the company's business in the region. Prior to joining Actis, Ngozi was VP Strategic Planning and Business Development for Pfizer Inc based in New York where she drove the financial and strategic planning processes of the company in addition to leading strategy projects and transactions for Pfizer. She was transferred to Nigeria in 2005 to run Pfizer's businesses in East, West and Central Africa, before being appointed in 2008 as Chief Executive of the Equity Vehicle for Health in Africa, an investment company focused on investing in private healthcare businesses in the continent. Ngozi has a background in strategic consulting, having spent seven years with McKinsey & Co, working principally in the consumer products and healthcare sectors. A US/Nigerian citizen, Ngozi was educated in the United States at Harvard University and started her career in corporate finance at JP Morgan.

 

Derek Lewis, who was appointed to the Board as a Non-executive Director in 2004 and has served as Senior Independent Director since 2008, will retire from the Board at the Company's next AGM in September 2012.

 

Richard Harvey, Chairman of PZ Cussons, said:

'We are delighted to welcome Helen and Ngozi to the Board. They each bring with them a wealth of relevant experience and insights which will be very valuable as we continue to grow the business. Their appointments will also serve to make the Board more representative of the Group's geographic profile and its customer base and reflect our belief in the benefits of diversity - in the Boardroom and across the whole of the Group."

"Although Derek will be remaining on the Board until next September, I would also like at this opportunity to thank him for his significant contribution to the Board and to the PZ Cussons Group since his appointment seven years ago, during which time PZ Cussons has delivered significant growth in shareholder value."

 

- Ends -

 

Notes: Ngozi Edozien is a Non-executive Director of Diamond Bank Plc, a company listed on the Nigerian Stock Exchange. There is no other information in relation to either appointment which is required to be disclosed by paragraph 9.6.13 of the Listing Rules.

 

For further information please contact:

 

PZ Cussons Plc Tel: 0161 435 1000

Brandon Leigh, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

John Olsen / James White

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADKCDQOBDDFDK
Date   Source Headline
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.